Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
16619 | 579 | 31.0 | 50% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
207 | 20341 | WEST NILE VIRUS//FLAVIVIRUS//DENGUE VIRUS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | YELLOW FEVER | Author keyword | 68 | 42% | 21% | 124 |
2 | YELLOW FEVER VACCINE | Author keyword | 40 | 58% | 8% | 45 |
3 | YELLOW FEVER VIRUS | Author keyword | 14 | 36% | 5% | 31 |
4 | VISCEROTROPIC DISEASE | Author keyword | 12 | 86% | 1% | 6 |
5 | 17D VACCINE | Author keyword | 5 | 63% | 1% | 5 |
6 | YELLOW FEVER VACCINATION | Author keyword | 5 | 63% | 1% | 5 |
7 | YFV | Author keyword | 4 | 75% | 1% | 3 |
8 | 17DD VACCINE | Author keyword | 3 | 100% | 1% | 3 |
9 | YELLOW FEVER VACCINE ASSOCIATED VISCEROTROPIC DISEASE | Author keyword | 3 | 100% | 1% | 3 |
10 | 17D | Author keyword | 3 | 50% | 1% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | YELLOW FEVER | 68 | 42% | 21% | 124 | Search YELLOW+FEVER | Search YELLOW+FEVER |
2 | YELLOW FEVER VACCINE | 40 | 58% | 8% | 45 | Search YELLOW+FEVER+VACCINE | Search YELLOW+FEVER+VACCINE |
3 | YELLOW FEVER VIRUS | 14 | 36% | 5% | 31 | Search YELLOW+FEVER+VIRUS | Search YELLOW+FEVER+VIRUS |
4 | VISCEROTROPIC DISEASE | 12 | 86% | 1% | 6 | Search VISCEROTROPIC+DISEASE | Search VISCEROTROPIC+DISEASE |
5 | 17D VACCINE | 5 | 63% | 1% | 5 | Search 17D+VACCINE | Search 17D+VACCINE |
6 | YELLOW FEVER VACCINATION | 5 | 63% | 1% | 5 | Search YELLOW+FEVER+VACCINATION | Search YELLOW+FEVER+VACCINATION |
7 | YFV | 4 | 75% | 1% | 3 | Search YFV | Search YFV |
8 | 17DD VACCINE | 3 | 100% | 1% | 3 | Search 17DD+VACCINE | Search 17DD+VACCINE |
9 | YELLOW FEVER VACCINE ASSOCIATED VISCEROTROPIC DISEASE | 3 | 100% | 1% | 3 | Search YELLOW+FEVER+VACCINE+ASSOCIATED+VISCEROTROPIC+DISEASE | Search YELLOW+FEVER+VACCINE+ASSOCIATED+VISCEROTROPIC+DISEASE |
10 | 17D | 3 | 50% | 1% | 4 | Search 17D | Search 17D |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | VISCEROTROPIC DISEASE | 40 | 77% | 5% | 27 |
2 | 17D | 39 | 74% | 5% | 29 |
3 | SERIOUS ADVERSE EVENTS | 30 | 54% | 7% | 38 |
4 | 1ST TIME VACCINATION | 24 | 91% | 2% | 10 |
5 | 17D VACCINE | 18 | 83% | 2% | 10 |
6 | 17DD VACCINE | 11 | 65% | 2% | 11 |
7 | 1ST RECORDED OUTBREAK | 8 | 70% | 1% | 7 |
8 | NEUROTROPIC DISEASE | 8 | 100% | 1% | 5 |
9 | ADVANCED AGE | 4 | 18% | 3% | 20 |
10 | VIRUS 17D | 3 | 100% | 1% | 3 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever | 2011 | 40 | 12 | 83% |
Review of the risks and benefits of yellow fever vaccination including some new analyses | 2012 | 28 | 87 | 61% |
The Safety of Yellow Fever Vaccine 17D or 17DD in Children, Pregnant Women, HIV+ Individuals, and Older Persons: Systematic Review | 2012 | 17 | 28 | 82% |
Review Article: Efficacy and Duration of Immunity after Yellow Fever Vaccination: Systematic Review on the Need for a Booster Every 10 Years | 2013 | 11 | 43 | 81% |
Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place? | 2009 | 58 | 22 | 91% |
Risk of yellow fever vaccine-associated viscerotropic disease among the elderly: A systematic review | 2013 | 6 | 24 | 100% |
Yellow fever: The recurring plague | 2004 | 51 | 49 | 76% |
Active and passive surveillance of yellow fever vaccine 17D or 17DD-associated serious adverse events: Systematic review | 2011 | 13 | 48 | 85% |
Safety profile of the yellow fever vaccine Stamaril (R): a 17-year review | 2013 | 5 | 48 | 77% |
Yellow fever vaccination: Is one dose always enough? | 2013 | 4 | 15 | 87% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TRAVEL HLTH NETWORK | 2 | 36% | 0.9% | 5 |
2 | GLOBAL ALERT PONSE HSE GAR | 2 | 67% | 0.3% | 2 |
3 | SERV MED INTERNE TROP | 2 | 67% | 0.3% | 2 |
4 | TECNOL IMUNOBIOL | 2 | 17% | 1.6% | 9 |
5 | BIOMANGUINHOS | 1 | 19% | 1.2% | 7 |
6 | TECNOL IMUNOL | 1 | 38% | 0.5% | 3 |
7 | ARBOVIROL VIRAL HEMORRHAG FEVER | 1 | 100% | 0.3% | 2 |
8 | CENEPI | 1 | 50% | 0.3% | 2 |
9 | NUCLEO POS CIENCIAS BIOL | 1 | 100% | 0.3% | 2 |
10 | WHO ABORATING ARBOVIRUS REFERENCE | 1 | 50% | 0.3% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000162086 | DENGUE VIRUS//FLAVIVIRUS//NS2B NS3 PROTEASE |
2 | 0.0000141379 | C18L GENE//GO GENE ONTOLOGY//KEGG KYOTO ENCYCLOPEDIA OF GENES AND GENOMES |
3 | 0.0000102357 | CULEX FLAVIVIRUS//TEMBUSU VIRUS//DUCK TEMBUSU VIRUS |
4 | 0.0000088132 | PROGRAM TRANSLAT IMMUNOVIROL BIODEF//MAYO VACCINE GRP//MAYO CLIN VACCINE GRP |
5 | 0.0000087812 | UNION PACIFIC RAILROAD//AFRICAN PEOPLE//AFRO ARGENTINES |
6 | 0.0000082768 | CHIKUNGUNYA VIRUS//CHIKUNGUNYA//CHIKUNGUNYA FEVER |
7 | 0.0000079139 | DENGUE//DENGUE HEMORRHAGIC FEVER//DENGUE FEVER |
8 | 0.0000070601 | GELATIN ALLERGY//VACCINE ALLERGY//ITCHING NODULE |
9 | 0.0000069219 | NYSSORHYNCHUS//ANOPHELES DARLINGI//CULICIDAE |
10 | 0.0000064063 | JAPANESE ENCEPHALITIS//JAPANESE ENCEPHALITIS VIRUS//IC51 |